Literature DB >> 19238650

Plasma concentrations of oral oxycodone are greatly increased in the elderly.

A Liukas1, K Kuusniemi, R Aantaa, P Virolainen, M Neuvonen, P J Neuvonen, K T Olkkola.   

Abstract

We compared the pharmacokinetics of 10 mg oral oxycodone in four groups of 10 patients each, aged 20-40, 60-70, 70-80, and 80-90 years. Patients aged 70-80 and 80-90 years had 50-80% higher mean exposure to oxycodone (P < 0.05) and a twofold higher plasma oxycodone concentration (P < 0.05) than the young adults 12 h after ingestion of the drug. Because oxycodone pharmacokinetics depend to a great extent on the age of the subject, it is important to titrate the analgesic dose individually, particularly in the elderly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19238650     DOI: 10.1038/clpt.2008.64

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  21 in total

Review 1.  Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment.

Authors:  Andrew J McLachlan; Sally Bath; Vasi Naganathan; Sarah N Hilmer; David G Le Couteur; Stephen J Gibson; Fiona M Blyth
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

2.  Effects of voriconazole co-administration on oxycodone-induced adverse events: a case in the retrospective survey.

Authors:  Masaaki Watanabe; Masato Homma; Kenji Momo; Yasushi Okoshi; Tetsuro Wada; Akira Hara; Shigeru Chiba; Yukinao Kohda
Journal:  Eur J Clin Pharmacol       Date:  2011-01-08       Impact factor: 2.953

3.  Influence of central nervous system-acting drugs on results of cognitive testing in geriatric inpatients.

Authors:  M Gogol; H Hartmann; S Wustmann; A Simm
Journal:  Z Gerontol Geriatr       Date:  2014-06       Impact factor: 1.281

Review 4.  The Role of Opioid Analgesics in Geriatric Pain Management.

Authors:  Jennifer Greene Naples; Walid F Gellad; Joseph T Hanlon
Journal:  Clin Geriatr Med       Date:  2016-08-09       Impact factor: 3.076

Review 5.  Use of hydromorphone, with particular reference to the OROS formulation, in the elderly.

Authors:  David Lussier; Ute Richarz; Gabriele Finco
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

6.  Elimination of intravenous oxycodone in the elderly: a pharmacokinetic study in postoperative orthopaedic patients of different age groups.

Authors:  Antti Liukas; Kristiina Kuusniemi; Riku Aantaa; Petri Virolainen; Mikko Neuvonen; Pertti J Neuvonen; Klaus T Olkkola
Journal:  Drugs Aging       Date:  2011-01-01       Impact factor: 3.923

Review 7.  Updated Clinical Pharmacokinetics and Pharmacodynamics of Oxycodone.

Authors:  Mari Kinnunen; Panu Piirainen; Hannu Kokki; Pauliina Lammi; Merja Kokki
Journal:  Clin Pharmacokinet       Date:  2019-06       Impact factor: 6.447

8.  Absorption of different oral dosage forms of oxycodone in the elderly: a cross-over clinical trial in patients undergoing cystoscopy.

Authors:  Merja Kokki; Pyry Välitalo; Ilpo Rasanen; Sirpa Aaltomaa; Ilkka Ojanperä; Matti Eskelinen; Hannu Kokki
Journal:  Eur J Clin Pharmacol       Date:  2012-03-27       Impact factor: 2.953

Review 9.  Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics.

Authors:  Christine K O'Neil; Joseph T Hanlon; Zachary A Marcum
Journal:  Am J Geriatr Pharmacother       Date:  2012-10-02

Review 10.  Cytochrome P450-mediated changes in oxycodone pharmacokinetics/pharmacodynamics and their clinical implications.

Authors:  Karin C Söderberg Löfdal; Marine L Andersson; Lars L Gustafsson
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.